These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1708317)

  • 41. Small intestinal mucin antigen (SIMA); a novel tumour marker in colorectal cancer?
    Eskelinen M; Pasanen P; Janatuinen E; Pettersson N; Linnane A; Alhava E
    Anticancer Res; 1995; 15(5B):2351-6. PubMed ID: 8572651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diagnostic value of radioimmunological analysis of CA-19-9 in the blood serum in cancer of the pancreas].
    Putseva NM; Chebotareva ED; Chernyĭ VA; Tashchiev RK
    Klin Khir (1962); 1989; (11):15-7. PubMed ID: 2625847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proteins in blood reveal pancreatic tumors.
    Schmidt C
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 25006198
    [No Abstract]   [Full Text] [Related]  

  • 44. Identification of serum biomarker signatures associated with pancreatic cancer.
    Wingren C; Sandström A; Segersvärd R; Carlsson A; Andersson R; Löhr M; Borrebaeck CA
    Cancer Res; 2012 May; 72(10):2481-90. PubMed ID: 22589272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum adenosine deaminase levels in pancreatic diseases.
    Ibiş M; Köklü S; Yilmaz FM; Başar O; Yilmaz G; Yüksel O; Yildirim E; Oztürk ZA
    Pancreatology; 2007; 7(5-6):526-30. PubMed ID: 17901713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Value of plasma testosterone, carcinoembryonic antigen and CA 19-9 in the differential diagnosis of pancreatic carcinoma and chronic pancreatitis].
    Jurkowska G; Kulpa J; Skrodzka D; Rogowski F
    Pol Arch Med Wewn; 1992 Nov; 88(5):302-9. PubMed ID: 1300550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Diagnostic value of serum angiopoietin-2 level in pancreatic cancer].
    Wan RG; Chen DB; Lou YG; Wang MF; Zhang QH; Jin DX; Zhou SH
    Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):47-9. PubMed ID: 21575464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer.
    Ventrucci M; Cipolla A; Racchini C; Casadei R; Simoni P; Gullo L
    Dig Dis Sci; 2004 Aug; 49(7-8):1149-55. PubMed ID: 15387337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The monoclonal antibody-defined CAR-3 antigen is a serological marker associated with pancreatic carcinoma.
    Prat M; Medico E; Piantino P; Bretti S; Rossini FP; Comoglio PM
    Int J Biol Markers; 1988; 3(1):29-35. PubMed ID: 2977786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evaluation of serum SC6 antigen using immunoradiometric assay for diagnosis of pancreatic cancer].
    Guo XZ; Liu MP; Li XX
    Zhonghua Nei Ke Za Zhi; 1992 Feb; 31(2):84-6, 125. PubMed ID: 1395920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CA 242 is a new tumor marker for pancreatic cancer.
    Röthlin MA; Joller H; Largiadèr F
    Cancer; 1993 Feb; 71(3):701-7. PubMed ID: 8431849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of cholestasis on CA 50 and CA 242 in pancreatic cancer and benign biliopancreatic diseases.
    Pålsson B; Masson P; Andrén-Sandberg A
    Scand J Gastroenterol; 1993 Nov; 28(11):981-7. PubMed ID: 8284635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is CA242 really a new tumour marker for pancreatic adenocarcinoma?
    Plebani M; Basso D; Navaglia F; D'Angeli F; Panozzo MP; Del Giudice G; Battistel M; Meggiato T; Del Favero G
    Oncology; 1995; 52(1):19-23. PubMed ID: 7800337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical utility of TPS, TPA and CA 19-9 measurement in pancreatic cancer.
    Plebani M; Basso D; Del Favero G; Ferrara C; Meggiato T; Fogar P; Mangano F; Ricciardi G; Burlina A
    Oncology; 1993; 50(6):436-40. PubMed ID: 8233283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neopterin serum levels in pancreatic adenocarcinoma.
    Manes G; Spada OA; Rabitti PG; Feola B; Misso S; Minerva A; Uomo G
    Int J Pancreatol; 1999 Feb; 25(1):31-7. PubMed ID: 10211419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A prospective study of the value of imaging, serum markers and their combination in the diagnosis of pancreatic carcinoma in symptomatic patients.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Anticancer Res; 1992; 12(6B):2309-14. PubMed ID: 1295478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal antibody defines CA 19-9 in pancreatic juices and sera.
    Schmiegel WH; Kreiker C; Eberl W; Arndt R; Classen M; Greten H; Jessen K; Kalthoff H; Soehendra N; Thiele HG
    Gut; 1985 May; 26(5):456-60. PubMed ID: 3858206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Ca 19-9 in the diagnosis of pancreatic carcinoma].
    Meggiato T; Basso D; Pasquali C; Angonese C; Bellinvia S; Del Favero G; Fabris C; Di Mario F; Plebani M; Pedrazzoli S
    Minerva Med; 1989 May; 80(5):431-4. PubMed ID: 2747969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The use of the carbohydrate antigen CA-19-9, the carcinoembryonic antigen and alpha fetoprotein in the diagnosis of pancreatic cancer].
    Skvortsov SV; Kalinin AV; Lytsar' BN
    Vestn Ross Akad Med Nauk; 1993; (4):47-9. PubMed ID: 7687486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer.
    Kawa S; Tokoo M; Hasebe O; Hayashi K; Imai H; Oguchi H; Kiyosawa K; Furuta S; Homma T
    Br J Cancer; 1994 Sep; 70(3):481-6. PubMed ID: 8080734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.